Güngör NK. Overweight and obesity in children and adolescents. J Clin Res Pediatr Endocrinol. 2014; 6(3): 129-43. doi: 10.4274/Jcrpe.1471.
Grossman DC, Bibbins-Domingo K, Curry SJ, Barry MJ, Davidson KW, Doubeni CA et al. Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2017; 317(23): 2417-26. doi: 10.1001/jama.2017.6803.
Nittari G, Scuri S, Petrelli F, Pirillo I, di Luca NM, Grappasonni I. Fighting obesity in children from European World Health Organization member states. Epidemiological data, medical-social aspects, and prevention programs. Clin Ter. 2019; 170(3): e223-e230. doi: 10.7417/CT.2019.2137.
Boswell N, Byrne R, Davies PSW. Family food environment factors associated with obesity outcomes in early childhood. BMC Obes. 2019; 6: 17. doi: 10.1186/s40608-019-0241-9.
Mancuso P, Bouchard B. The Impact of Aging on Adipose Function and Adipokine Synthesis. Front Endocrinol (Lausanne). 2019; 10: 137. doi: 10.3389/fendo.2019.00137.
Yeung EH, Sundaram R, Xie Y, Lawrence DA. Newborn adipokines and early childhood growth. Pediatr Obes. 2018; 13(8): 505-13. doi: 10.1111/ijpo.12283.
Tutelyan V.A., Baturin A.K., Kon I.Ya., Martinchik A.N., Uglitskikh A.K., Korosteleva M.M. et al. Prevalence of obesity and overweight among children in Russia: multicenter study. Pediatriya. Zhurnal im. G. N. Speranskogo. 2014; 93(5): 28-31.
Belyaeva I.A., Bombardirova E.P., Smirnov I.E., Kharitonova N.A. Neurotrophic aspects of feeding preterm infants. Rossiyskiy pediatricheskiy zhurnal. 2015; 18(5): 30-7.
Ergören MC, Söyler G, Sah H, Becer E. Investigation of potential genomic biomarkers for obesity and personalized medicine. Int J Biol Macromol. 2019; 122: 493-8. doi: 10.1016/j.ijbiomac.2018.10.059.
Postnikova E.V., Smirnov I.E., Maslova O.I., Namazova-Baranova L.S. Clinical and pathogenetic significance of endothelial dysfunction in the formation of obesity in children. Rossiyskiy pediatricheskiy zhurnal. 2013; 5: 36-40.
Giannakopoulos A, Lazopoulou N, Pervanidou P, Kanaka-Gantenbein C. The Impact of Adiposity and Puberty on Thyroid Function in Children and Adolescents. Child Obes. 2019. doi: 10.1089/chi.2019.0025.
Gross AC, Kaizer AM, Vock DM, Siddiqui S, Fox CK. Cognitive, emotional, and behavioral contributors to early childhood weight status. J Child Health Care. 2019: 1367493519852462. doi: 10.1177/1367493519852462.
Zhu Q, Glazier BJ, Hinkel BC, Cao J, Liu L, Liang C, Shi H. Neuroendocrine Regulation of Energy Metabolism Involving Different Types of Adipose Tissues. Int J Mol Sci. 2019; 20(11). doi: 10.3390/ijms20112707.
Vavilova T.P., Pleten A.P., Mikheev R.K. Biological role of adipokines as markers of pathological conditions. Voprosy pitaniya. 2017; 86(2): 5-13. (in Russian)
Titov V.N. The fatty cell. The visceral fatty tissue. Effect of humoral mediator leptin in autocrine way and paracrin cenosises of cells.Two phylogenetically, functionally and regulatory different pools of fatty tissue in vivo. Klinicheskaya laboratornaya diagnostika. 2015; 69(8): 4-13. (in Russian)
Scheja L, Heeren J. Metabolic interplay between white, beige, brown adipocytes and the liver. J Hepatol. 2016; 64(5): 1176-86. doi: 10.1016/j.jhep.2016.01.025.
Jaleel A, Aheed B, Jaleel S, Majeed R, Zuberi A, Khan S et al. Association of adipokines with obesity in children and adolescents. Biomark Med. 2013; 7(5): 731-5. doi: 10.2217/bmm.13.41.
Wu Y, Yu X, Li Y, Li G, Cheng H, Xiao X et al. Adipose Tissue Mediates Associations of Birth Weight with Glucose Metabolism Disorders in Children. Obesity (Silver Spring). 2019; 27(5): 746-55. doi: 10.1002/oby.22421.
Stroescu RF, Mărginean O, Bizerea T, Gafencu M, Voicu A, Doroș G. Adiponectin, leptin and high sensitivity C-reactive protein values in obese children - important markers for metabolic syndrome? J Pediatr Endocrinol Metab. 2019; 32(1): 27-31. doi: 10.1515/jpem-2018-0378.
Spurná J, Karásek D, Kubíčková V, Goldmannová D, Krystyník O, Schovánek J et al. Relationship of Selected Adipokines with Markers of Vascular Damage in Patients with Type 2 Diabetes. Metab Syndr Relat Disord. 2018; 16(5): 246-53. doi: 10.1089/met.2017.0179.
Rivera P, Martos-Moreno GÁ, Barrios V, Suárez J, Pavón FJ, Chowen JA et al. A novel approach to childhood obesity: circulating chemokines and growth factors as biomarkers of insulin resistance. Pediatr Obes. 2019; 14(3): e12473. doi: 10.1111/ijpo.12473.
Shelly C, Grandjean P, Oulhote Y, Plomgaard P, Frikke-Schmidt R, Nielsen F et al. Early life exposures to perfluoroalkyl substances in relation to adipokine hormone levels at birth and during childhood. J Clin Endocrinol Metab. 2019. doi: 10.1210/jc.2019-00385.
Morais TC, de Abreu LC, de Quental OB, Pessoa RS, Fujimori M, Daboin BEG et al. Obesity as an Inflammatory Agent Can Cause Cellular Changes in Human Milk due to the Actions of the Adipokines Leptin and Adiponectin. Cells. 2019; 8(6). doi: 10.3390/cells8060519.
Jeffery AN, Murphy MJ, Metcalf BS, Hosking J, Voss LD, English P et al. Adiponectin in childhood. Int J Pediatr Obes. 2008; 3(3): 130-40. doi: 10.1080/17477160801954538.
Du Y, Zhang T, Sun D, Li C, Bazzano L, Qi L et al. Effect of Serum Adiponectin Levels on the Association Between Childhood Body Mass Index and Adulthood Carotid Intima-Media Thickness. Am J Cardiol. 2018; 121(5): 579-83. doi: 10.1016/j.amjcard.2017.11.029.
Lausten-Thomsen U, Lund MAV, Frithioff-Bøjsøe C, Hedley PL, Pedersen O, Hansen T et al. Reference values for leptin/adiponectin ratio in healthy children and adolescents. Clin Chim Acta. 2019; 493: 123-8. doi: 10.1016/j.cca.2019.03.004.
Martos-Moreno GÁ, Mastrangelo A, Barrios V, García A, Chowen JA, Rupérez FJ et al. Metabolomics allows the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children. Int J Obes (Lond). 2017; 41(10): 1473-80. doi: 10.1038/ijo.2017.137.
Cohen P, Spiegelman BM. Cell biology of fat storage. Mol Biol Cell. 2016; 27(16): 2523-7. doi: 10.1091/mbc.E15-10-0749.
Frühbeck G, Catalán V, Rodríguez A, Ramírez B, Becerril S, Salvador J et al. Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome. Sci Rep. 2017; 7(1): 6619. doi: 10.1038/s41598-017-06997-0.
Gioldasi S, Karvela A, Rojas-Gil AP, Rodi M, de Lastic AL, Thomas I et al. Metabolic Association between Leptin and the Corticotropin Releasing Hormone. Endocr Metab Immune Disord Drug Targets. 2019. doi: 10.2174/1871530319666190206165626.
Pires A, Martins P, Pereira AM, Marinho J, Vaz Silva P, Marques M et al. Pro-inflammatory triggers in childhood obesity: correlation between leptin, adiponectin and high-sensitivity C-reactive protein in a group of obese Portuguese children. Rev Port Cardiol. 2014; 33(11): 691-7. doi: 10.1016/j.repc.2014.04.004.
Reinehr T, Roth CL. Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population. Curr Diab Rep. 2018; 18(12): 131. doi: 10.1007/s11892-018-1110-5.
Rendo-Urteaga T, Ferreira de Moraes AC, Torres-Leal FL, Manios Y, Gottand F, Sjöström M et al. Leptin and adiposity as mediators on the association between early puberty and several biomarkers in European adolescents: the HELENA Study. J Pediatr Endocrinol Metab. 2018; 31(11): 1221-9. doi: 10.1515/jpem-2018-0120.
Al-Rawaf HA. Circulating microRNAs and adipokines as markers of metabolic syndrome in adolescents with obesity. Clin Nutr. 2018. doi: 10.1016/j.clnu.2018.09.024.
Faulkner JL, Belin de Chantemèle EJ. Leptin and Aldosterone. Vitam Horm. 2019; 109: 265-84. doi: 10.1016/bs.vh.2018.09.003.
Buyukinan M, Atar M, Can U, Pirgon O, Guzelant A, Deniz I. The Association Between Serum Vaspin and Omentin-1 Levels in Obese Children with Metabolic Syndrome. Metab Syndr Relat Disord. 2018; 16(2): 76-81. doi: 10.1089/met.2017.0133.
Lausten-Thomsen U, Christiansen M, Hedley PL, Nielsen TRH, Fonvig CE, Pedersen O et al. Reference values for fasting serum resistin in healthy children and adolescents. Clin Chim Acta. 2017; 469: 161-5. doi: 10.1016/j.cca.2017.04.002.
Acquarone E, Monacelli F, Borghi R, Nencioni A, Odetti P. Resistin: A reappraisal. Mech Ageing Dev. 2019; 178: 46-63. doi: 10.1016/j.mad.2019.01.004.
Lee MW, Lee M, Oh KJ. Adipose Tissue-Derived Signatures for Obesity and Type 2 Diabetes: Adipokines, Batokines and MicroRNAs. J Clin Med. 2019; 8(6). pii: E854. doi: 10.3390/jcm8060854.
Jamurtas AZ, Stavropoulos-Kalinoglou A, Koutsias S, Koutedakis Y, Fatouros I. Adiponectin, Resistin, and Visfatin in Childhood Obesity and Exercise. Pediatr Exerc. Sci. 2015; 27(4): 454-62. doi: 10.1123/pes.2014-0072.
Bergman RN, Piccinini F, Kabir M, Ader M. Novel aspects of the role of the liver in carbohydrate metabolism. Metabolism. 2019. doi: 10.1016/j.metabol.2019.05.011.
Unamuno X, Gómez-Ambrosi J, Rodríguez A, Becerril S, Frühbeck G, Catalán V. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest. 2018; 48(9):e12997. doi: 10.1111/eci.12997.
Zigman JM, Bouret SG, Andrews ZB. Obesity Impairs the Action of the Neuroendocrine Ghrelin System. Trends Endocrinol Metab. 2016; 27(1): 54-63. doi: 10.1016/j.tem.2015.09.010.
Cui H, López M, Rahmouni K. The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol. 2017; 13(6): 338-51. doi: 10.1038/nrendo.2016.222.
Ballerini MG, Bergadá I, Rodríguez ME, Keselman A, Bengolea VS, Pipman V et al. Insulin level and insulin sensitivity indices among healthy children and adolescents. Arch Argent Pediatr. 2016; 114(4): 329-36. doi:10.5546/aap.2016.329.
Pathak NM, Pathak V, Gault VA, McClean S, Irwin N, Flatt PR. Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential. Biochem Pharmacol. 2018; 155: 264-74. doi: 10.1016/j.bcp.2018.07.021.
Karki S. FSP27 and Links to Obesity and Diabetes Mellitus. Curr Obes Rep. 2019. doi: 10.1007/s13679-019-00343-3.
Ahlsson F, Diderholm B, Ewald U, Jonsson B, Forslund A, Stridsberg M et al. Adipokines and their relation to maternal energy substrate production, insulin resistance and fetal size. Eur J Obstet Gynecol Reprod Biol. 2013; 168(1): 26-9. doi: 10.1016/j.ejogrb.2012.12.009.
Nourbakhsh M, Nourbakhsh M, Gholinejad Z, Razzaghy-Azar M. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome. Scand J Clin Lab Invest. 2015; 75(2): 183-8. doi: 10.3109/00365513.2014.1003594.
Rodríguez A, Ezquerro S, Méndez-Giménez L, Becerril S, Frühbeck G. Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. Am J Physiol Endocrinol Metab. 2015; 309(8): E691-714. doi: 10.1152/ajpendo.00297.2015.
Smirnova G.I. Serum glucagon and insulin levels in obese children. Pediatriya. 1977; 9: 23-4. (in Russian)
Smirnova G.I.,Zubovskiy G.A., Leonova L.N. The content of glucagon, C-peptide and insulin in the blood of healthy children. Pediatriya. 1978; 8: 38-42. (in Russian)
Lachin J.M., McGee P., Palmer J.P., Group for the D.R. Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial. Diabetes. 2014; 63(2): 739-48.
Nakamura A, Miyoshi H, Ukawa S, Nakamura K, Nakagawa T, Terauchi Y et al. Proinsulin is sensitive to reflect glucose intolerance. J Diabetes Investig. 2019. doi: 10.1111/jdi.13106
Khodjieva M.V., Skvortsova V.A., Borovik T.E., Namazova-Baranova L.S., Margieva T.V., Bushueva T.V., et al. Estimation of physical development of children of primary school age (7-10 years):results from a cohort study. Pediatricheskaya farmakologiya. 2016; 13(4): 362-6. (in Russian)